SEDOR PHARMACEUTICALS is targeting investment opportunities in the biopharmaceutical industry with the following characteristics:
Structure
Acquisition of company, product portfolio, or manufacturing facility; Product licensing agreement
Stage
Launched, near-launch, or early stage with low-development risk
Financials
Licensed products with funding needs, underperforming or non-strategic assets producing revenues
Products
Branded specialty segments with promotional sensitivity and/or generics with growth opportunity
Geography
North American and European markets
Exit
Mid-term timeframe (2-5 years) in sectors attractive to strategic buyers